image
Healthcare - Biotechnology - NASDAQ - US
$ 4.97
5.52 %
$ 1.18 B
Market Cap
-15.53
P/E
BALANCE SHEET
298 M ASSETS
56.57%
131 M LIABILITIES
42.54%
167 M EQUITY
69.65%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Ardelyx, Inc.
image
Current Assets 246 M
Cash & Short-Term Investments 184 M
Receivables 22 M
Other Current Assets 39.8 M
Non-Current Assets 51.5 M
Long-Term Investments 0
PP&E 6.6 M
Other Non-Current Assets 44.9 M
Current Liabilities 50.4 M
Accounts Payable 11.1 M
Short-Term Debt 8.87 M
Other Current Liabilities 30.4 M
Non-Current Liabilities 80.4 M
Long-Term Debt 51.5 M
Other Non-Current Liabilities 28.8 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
ASSETS
Cash & Cash Equivalents 21.5 96.1 72.4 91.0 181.1 78.8 75.4 74.6 107.0 107.3 34.4 32.9
Short Term Investments 162.8 27.8 44.3 95.5 66.4 89.3 58.6 126.2 0 0 0 0
Receivables 22.0 7.7 0.5 0 0.8 5.1 10.8 0 0 2.6 6.4 3.1
Inventory 12.4 3.3 0 0 1 0 1 0 0 1 1 0
Other Current Assets 27.3 18.7 16.5 8.2 3.8 3.2 4.9 6.3 5.0 1.2 1.0 1.8
Total Current Assets 246.1 154.5 134.8 195.2 252.4 177.7 149.9 204.0 112.2 111.3 41.8 36.9
PP&E 6.6 10.5 15.1 4.2 7.4 5.6 8.0 9.0 4.7 2.1 0.5 0.8
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 2.1 0 0 0 0 100 K 0 0 0
Other Long Term Assets 44.9 25.1 0 0 0 0 0 0.1 100 K 0 0.5 0.2
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 297.6 190.1 149.9 201.6 259.8 183.3 157.9 213.1 116.9 113.4 42.9 37.9
LIABILITIES
Accounts Payable 11.1 10.9 4.3 5.6 2.2 1.1 3.9 5.6 2.8 3.1 2.3 1.1
Short Term Debt 8.9 34.5 39.2 8.4 6.4 0 0 0 0 0 0 0
Other Current Liabilities 23.2 16.0 9.3 10.2 9.1 15.6 13.9 13.6 4.9 2.4 1.0 1.7
Total Current Liabilities 50.4 74.6 57.5 28.4 22.2 17.7 17.9 19.2 7.7 5.6 17.1 16.8
Long Term Debt 51.5 5.9 9.7 47.0 50.9 49.2 0 0 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 20.2 11.3 0 0 0 0.6 0.7 0.8 0.3 0.1 6.6 3.2
Total Liabilities 130.8 91.7 67.3 75.5 73.1 67.5 18.6 20.0 8.0 52.7 50.2 39.1
EQUITY
Common Stock 23 K 20 K 13 K 9 K 9 K 6 K 5 K 5 K 3 K 2 K 0 0
Retained Earnings (846.2) (780.1) (712.9) (554.8) (460.5) (365.5) (278.2) (213.9) (101.5) (71.9) (68.7) (62.1)
Other Accumulative Comprehensive Income/Loss 0.2 54 K 6 K 4 K 20 K 38 K 47 K 71 K (3.8) (3.6) (3.3) (2.7)
Total Equity 166.8 98.3 82.6 126.1 186.7 115.8 139.3 193.2 108.9 60.7 (7.3) (1.2)
Total Liabilities and Equity 297.6 190.1 149.9 201.6 259.8 183.3 157.9 213.1 116.9 113.4 42.9 37.9
SHARES OUTSTANDING
Common Shares Outstanding 219.3 158.7 104.2 89.6 64.5 56.2 47.4 40.1 22.9 10.2 13.3 13.3